WALPOLE, Mass.—Building on $40 billion of U.S. investment over the last 15 years, Siemens recently broke ground on a major expansion of a key Siemens Healthineers manufacturing and R&D facility for laboratory diagnostics in Walpole, Massachusetts that will create up to 700 new high-tech jobs over the next 10 years. Siemens’ $300 million investment in Walpole exemplifies the company’s broader strategy for creating local value in the U.S.—its largest market—by furthering the company’s ability to transform customers’ healthcare operations in order to improve the lives of the patients they serve.
“Healthcare is changing all over the world, and these changes are opening up great opportunities for providers, for patients—and for our company,” said Michael Sen, member of the managing board of Siemens AG and Siemens Healthcare GmbH supervisory board chairman, in a press release. “Today, we provide more than 10 billion laboratory diagnostics tests each year. Our mission is to extend this reach even further, and Walpole will play a major role in this effort. That’s why we’re investing 300 million dollars here—one of the largest single capital investments of Siemens Healthcare in the U.S. ever. We look forward to innovations from here—innovations that will benefit our customers, that will benefit Siemens and, most of all, that will benefit patients.”
“Siemens has been doing business in the United States for more than 160 years,” said Lisa Davis, chair and CEO of Siemens Corporation and member of the managing board of Siemens AG, in a statement. “We not only deliver products and solutions to America, but the Walpole expansion demonstrates our passion for making things here, hiring here, and working closely with U.S. customers. By investing in advanced manufacturing right here in the U.S., Siemens creates value for customers and communities, produces high-wage jobs, increases exports, and creates more orders for local businesses of all sizes.”
The company’s products are used in 8 out of 10 U.S. hospitals and in all 15 hospitals on U.S. News & World Report’s 2015-16 Best Hospitals Honor Roll, Siemens said in the press release.
“Our administration has reinforced our commitment to life sciences, research, and development by investing up to $500 million for strategic investments to support companies in innovation and technology,” said Massachusetts Governor Charlie Baker. “Thanks to companies like Siemens,
Massachusetts continues to be a global leader in the industry and we welcome their growth and investment in Walpole to support the global healthcare market.”
Siemens (www.siemens.com/global/en/home.html) invests more than $1 billion annually in U.S. R&D. The Walpole facility, in turn, is one of Siemens’ more than 60 U.S. manufacturing sites that work with more than 36,000 U.S. suppliers. Siemens’ manufacturing sites last year shipped more than $5 billion worth of products around the world, making the company a net exporter.